Probiotics and prevention of Clostridium difficile infection

被引：30
|
作者：
Goldstein, E. J. C. [1 ,2 ]
Johnson, S. J. [3 ]
Maziade, P. -J. [4 ]
Evans, C. T. [5 ,6 ,7 ]
Sniffen, J. C. [8 ]
Millette, M. [9 ]
McFarland, L. V. [10 ]
机构：
[1] RM Alden Res Lab, Santa Monica, CA USA
[2] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA
[3] Loyola Sch Med, Chicago, IL USA
[4] Pierre Le Gardeur Hosp, Terrebonne, PQ, Canada
[5] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA
[6] Northwestern Univ, Ctr Healthcare Studies, Chicago, IL 60611 USA
[7] Edward Hines Jr VA Hosp, Chicago, IL USA
[8] Florida Hosp, Orlando, FL USA
[9] BioK Plus Int Inc, Laval, PQ, Canada
[10] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA
来源：
ANAEROBE | 2017年 / 45卷
关键词：
Probiotic; Bio-K; Saccharomyces boulardii; C; difficile; Lactobacillus rhamnosus GG; Lactobacillus acidophilus CL1285; Lactobacillus casei LBC80R; Lactobacillus rhamnosus CLR2; LACTOBACILLUS-ACIDOPHILUS CL1285; ANTIBIOTIC-ASSOCIATED DIARRHEA; CASEI LBC80R; COST-EFFECTIVENESS; DOUBLE-BLIND; COMBINATION; EPIDEMIOLOGY; INPATIENTS; SURVIVAL; RELAPSE;
D O I：
10.1016/j.anaerobe.2016.12.007
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The role of probiotics as adjunctive measures in the prevention of Clostridium difficile infection (CDI) has been controversial. However, a growing body of evidence has suggested that they have a role in primary prevention of CDI. Elements of this controversy are reviewed and the proposed mechanisms of action, the value and cost effectiveness of probiotics are addressed with a focus on three agents, Saccharomyces boulardii, Lactobacillus rhamnosus GG and the combination of Lactobacillus acidophilus CL1285, Lactobacillus casei LBC8OR, Lactobacillus rhamnosus CLR2 (Bio-K+). (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：114 / 119
页数：6
相关论文
共 50 条
  • [31] Clostridium difficile Infection
    Heinlen, Latisha
    Ballard, Jimmy D.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 340 (03) : 247 - 252
  • [32] Clostridium difficile infection
    Groschel, DHM
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1996, 33 (03) : 203 - 245
  • [33] Microbial Preparations (Probiotics) for the Prevention of Clostridium difficile Infection in Adults and Children: An Individual Patient Data Meta-analysis of 6,851 Participants
    Johnston, Bradley C.
    Lytvyn, Lyubov
    Lo, Calvin Ka-Fung
    Allen, Stephen J.
    Wang, Duolao
    Szajewska, Hania
    Miller, Mark
    Ehrhardt, Stephan
    Sampalis, John
    Duman, Deniz G.
    Pozzoni, Pietro
    Colli, Agostino
    Lonnermark, Elisabet
    Selinger, Christian P.
    Wong, Samford
    Plummer, Susan
    Hickson, Mary
    Pancheva, Ruzha
    Hirsch, Sandra
    Klarin, Bengt
    Goldenberg, Joshua Z.
    Wang, Li
    Mbuagbaw, Lawrence
    Foster, Gary
    Maw, Anna
    Sadeghirad, Behnam
    Thabane, Lehana
    Mertz, Dominik
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2018, 39 (07) : 771 - 781
  • [34] Diagnosis and Management of Clostridium difficile Infection
    Dupont, Herbert L.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (10) : 1216 - 1223
  • [35] Diagnosis and Management of Clostridium difficile Infection
    Korman, Tony M.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 36 (01) : 31 - 43
  • [36] Bundling Probiotics With Antimicrobial Stewardship Programs for the Prevention of Clostridiodes difficile Infections in Acute Care Hospitals
    Kullar, Ravina
    Johnson, Stuart
    McFarland, Lynne V.
    Goff, Debra A.
    Goldstein, Ellie J. C.
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2020, 28 (03) : 123 - 129
  • [37] Gut solutions to a gut problem: bacteriocins, probiotics and bacteriophage for control of Clostridium difficile infection
    Rea, Mary C.
    Alemayehu, Debebe
    Ross, R. Paul
    Hill, Colin
    JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 62 : 1369 - 1378
  • [38] A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO)
    Barker, Anna K.
    Duster, Megan
    Valentine, Susan
    Hess, Timothy
    Archbald-Pannone, Laurie
    Guerrant, Richard
    Safdar, Nasia
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (11) : 3177 - 3180
  • [39] Vaccines in development for the primary prevention of Clostridium difficile infection
    Legenza, Laurel M.
    Barnett, Susanne G.
    Rose, Warren E.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2017, 57 (04) : 547 - 549
  • [40] The Use of Probiotics in the Prevention and Treatment of Antibiotic-Associated Diarrhea With Special Interest in Clostridium difficile-Associated Diarrhea
    Rohde, Cynthia L.
    Bartolini, Vickie
    Jones, Nicole
    NUTRITION IN CLINICAL PRACTICE, 2009, 24 (01) : 33 - 40
12345